Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

Investigation of Metabolite Differences Between Taiwanese Metabolic Syndrome and Healthy Group Through Metabolomics

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Inclusion Criteria:

• Capable adults weigh ≥ 50 kg

Exclusion Criteria:

• Not Taiwanese
• Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month
• Incapacity
• Limited disposing capacity
• Mental disorders or intellectual disabilities